Document Detail

An update on therapeutic uses of radiotracers in neoplastic disease.
MedLine Citation:
PMID:  3885398     Owner:  NLM     Status:  MEDLINE    
The key to delivering radiation to a lesion by means of internally administered radiopharmaceuticals is specificity of localization (a high lesion-background ratio). Factors that may limit this localization are pointed out. Potential alteration of the residence time within the lesion and use of radiation-sensitizing agents may bring new applications for radionuclides in therapy. The most common therapeutic applications of radiopharmaceuticals are outlined.
R P Spencer
Related Documents :
11004718 - Adrenal incidentaloma.
10339708 - Reappearing ct lesions: 4 cases.
9224758 - Multifocal hemangioendothelioma of the fetus and placenta.
17041748 - An evidence-based, multidisciplinary approach to the clinical considerations, managemen...
10877088 - Polyarteritis nodosa involving the hepatobiliary system in an eight-year-old girl with ...
23982828 - Tiny hair tuft: a clue for occipital cephalocele.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Seminars in nuclear medicine     Volume:  15     ISSN:  0001-2998     ISO Abbreviation:  Semin Nucl Med     Publication Date:  1985 Jan 
Date Detail:
Created Date:  1985-05-08     Completed Date:  1985-05-08     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  1264464     Medline TA:  Semin Nucl Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  21-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Beta Particles / therapeutic use
Middle Aged
Neoplasms / radiotherapy*
Radioisotopes / therapeutic use*
Grant Support
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of nuclear medicine in chemotherapy of malignant lesions.
Next Document:  Contribution of radionuclide imaging to radiation oncology.